Enhanced expression of β3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines

Glycobiology

Volumn 19, Issue 4, 2009, Pages 418-427

  Lin, Chi Hung ^a,b   Fan, Yao Yun ^c,d   Chen, Yen Ying ^c,d   Wang, Shih Hsin ^c,d   Chen, Chun I ^c,d   Yu, Lung Chih ^c,d   Khoo, Kay Hooi ^a,d  

^a ACADEMIA SINICA   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

3 galactosyltransferase; 3GalT5; Extended type 1 chain; Glycomics; Mass spectrometry

Indexed keywords

BETA 3 GALACTOSYLTRANSFERASE 5; GALACTOSYLTRANSFERASE; GLYCOSYLTRANSFERASE; LACTOSYLCERAMIDE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE;

ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STRUCTURE; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ANTIGENS, CD; CARBOHYDRATE CONFORMATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTOSYLCERAMIDES; MASS SPECTROMETRY; OLIGOSACCHARIDES;

EID: 62349106804     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn156     Document Type: Article

References (24)

1. Amado M, Almeida R, Schwientek T, Clausen H. 1999. Identification and characterization of large galactosyltransferase gene families: Galactosyltransferases for all functions. Biochim Biophys Acta. 1473:35-53.
2. Angstrom J, Larsson T, Hansson GC, Karlsson KA, Henry S. 2004. Default biosynthesis pathway for blood group-related glycolipids in human small intestine as defined by structural identification of linear and branched glycosylceramides in a group O Le(a-b-) nonsecretor. Glycobiology. 14:1-12.
3. Dell A, Reason AJ, Khoo KH, Panico M, McDowell RA, Morris HR. 1994. Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol 230:108-132.
4. Dunn CA, Medstrand P, Mager DL. 2003. An endogenous retroviral long terminal repeat is the dominant promoter for human β1,3-galactosyltransferase 5 in the colon. Proc Natl Acad Sci USA 100:12841-12846.
5. Fan YY, Yu SY, Ito H, Kameyama A, Sato T, Lin CH, Yu LC, Narimatsu H, Khoo KH. 2008. Identification of further elongation and branching of dimeric type 1 chain on lactosylceramides from colonic adenocarcinoma by tandem mass spectrometry sequencing analyses. J Biol Chem. 283:16455-16468.
6. Holmes EH. 1989. Characterization and membrane organization of β1←3- and β1←4-galactosyltransferases from human colonic adenocarcinoma cell lines Colo 205 and SW403: Basis for preferential synthesis of type 1 chain lacto-series carbohydrate structures. Arch Biochem Biophys. 270:630-646.
7. Holmes EH, Greene TG. 1993. De novo synthesis of type 1 lacto-series glycolipids in human colonic adenocarcinoma cells: Efficient synthesis of the Le(a) antigen and absence of brefeldin A-induced inhibition of its synthesis in Colo 205 cells. Arch Biochem Biophys. 305:328-340.
8. Holmes EH, Hakomori S, Ostrander GK. 1987. Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed β1←3N-acetylglucosaminyltransferase. J Biol Chem. 262:15649-15658.
9. Ishida H, Togayachi A, Sakai T, Iwai T, Hiruma T, Sato T, Okubo R, Inaba N, Kudo T, Gotoh M, et al. 2005. A novel β1,3-N acetylglucosaminyltransferase (β3Gn-T8), which synthesizes poly-N acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett. 579:71-78.
10. Isshiki S, Kudo T, Nishihara S, Ikehara Y, Togayachi A, Furuya A, Shitara K, Kubota T, Watanabe M, Kitajima M, et al. 2003. Lewis type 1 antigen synthase (β3Gal-T5) is transcriptionally regulated by homeoproteins. J Biol Chem. 278:36611-36620.
11. Isshiki S, Togayachi A, Kudo T, Nishihara S, Watanabe M, Kubota T, Kitajima M, Shiraishi N, Sasaki K, Andoh T, et al. 1999. Cloning, expression, and characterization of a novel UDP-galactose:Β-N acetylglucosamine β1,3-galactosyltransferase (β3Gal-T5) responsible for synthesis of type 1 chain in colorectal and pancreatic epithelia and tumor cells derived therefrom. J Biol Chem. 274:12499-12507.
12. Ito H, Tashiro K, Stroud MR, Orntoft TF, Meldgaard P, Singhal AK, Hakomori S. 1992. Specificity and immunobiological properties of monoclonal antibody IMH2, established after immunization with Le(b)/ Le(a) glycosphingolipid, a novel extended type 1 chain antigen. Cancer Res. 52:3739-3745.
13. Karlsson KA, Larson G. 1981. Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a-b+) secretor. J Biol Chem. 256:3512-3524.
14. Lin CH, Lin CW, Khoo KH. 2008. Proteomic identification of specific glycosyltransferases functionally implicated for the biosynthesis of a targeted glyco-epitope. Proteomics. 8:475-483.
15. Mare L, Trinchera M. 2007. Comparative analysis of retroviral and native promoters driving expression of β1,3-galactosyltransferase β3Gal-T5 in human and mouse tissues. J Biol Chem. 282:49-57.
16. Muto S, Sakuma K, Taniguchi A, Matsumoto K. 1999. Human mannose-binding lectin preferentially binds to human colon adenocarcinoma cell lines expressing high amount of Lewis A and Lewis B antigens. Biol Pharm Bull. 22:347-352.
17. Narimatsu H. 2006. Human glycogene cloning: Focus on β3-glycosyltransferase and β4-glycosyltransferase families. Curr Opin Struct Biol. 16:567-575.
18. Salvini R, Bardoni A, Valli M, Trinchera M. 2001. β1,3-Galactosyltransferase β3Gal-T5 acts on the GlcNAcβ1←3Galβ1←4GlcNAcβ1←R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas. J Biol Chem. 276:3564-3573.
19. Seko A, Ohkura T, Kitamura H, Yonezawa S, Sato E, Yamashita K. 1996. QuantitativeBdifferences in GlcNAc:Β1←3 and GlcNAc:β1←4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa. Cancer Res. 56:3468-3473.
20. Shiraishi N, Natsume A, Togayachi A, Endo T, Akashima T, Yamada Y, Imai N, Nakagawa S, Koizumi S, Sekine S, et al. 2001. Identification and characterization of three novel β1,3-N acetylglucosaminyltransferases structurally related to the β1,3-galactosyltransferase family. J Biol Chem. 276:3498-3507.
21. Stroud MR, Levery SB, Nudelman ED, Salyan ME, Towell JA, Roberts CE, Watanabe M, Hakomori S. 1991. Extended type 1 chain glycosphingolipids: Dimeric Lea (III4V4Fuc2Lc6) as human tumor-associated antigen. J Biol Chem. 266:8439-8446.
22. Terada M, Khoo KH, Inoue R, Chen CI, Yamada K, Sakaguchi H, Kadowaki N, Ma BY, Oka S, Kawasaki T, et al. 2005. Characterization of oligosaccharide ligands expressed on SW1116 cells recognized by mannan-binding protein. A highly fucosylated polylactosamine type N glycan. J Biol Chem. 280:10897-10913.
23. Togayachi A, Akashima T, Ookubo R, Kudo T, Nishihara S, Iwasaki H, Natsume A, Mio H, Inokuchi J, Irimura T, et al. 2001. Molecular cloning and characterization of UDP-GlcNAc:lActosylceramide β1,3-N acetylglucosaminyltransferase (β3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J Biol Chem 276:22032-22040.
24. Yu SY, Wu SW, Khoo KH. 2006. Distinctive characteristics of MALDI-Q/TOF and TOF/TOF tandem mass spectrometry for sequencing of permethylated complex type N-glycans. Glycoconj J. 23:355-369.